Menu

Blog posts March 2024

Gramercy Funds Management LLC Names Emerging Markets Expert Hamad Almudhaf as Managing Director, Head of International Capital Markets

GREENWICH, Conn. - Tuesday, 19. March 2024 AETOSWire 

(BUSINESS WIRE) -- Gramercy Funds Management LLC (“Gramercy”), a $6 billion, global emerging markets investment manager, today announced that Hamad Almudhaf has joined the firm in a newly created role, Head of International Capital Markets. M…

Read more

AMWC 2024: Galderma to Share New Data From Its Leading Injectable Aesthetic Portfolio

  Galderma’s diverse portfolio and educational efforts will be highlighted in 16 posters, and two sponsored symposia, exploring insights from the ground-breaking ‘NEXT by Galderma’ future aesthetic trends report and the use of Sculptra® for the body, as we celebrate its 25th anniversary
   …

Read more

Quectel IoT Modules Significantly More Secure Than Industry Average According to Finite State

VANCOUVER, British Columbia - Monday, 18. March 2024 AETOSWire 

(BUSINESS WIRE) -- Quectel Wireless Solutions, a global IoT solutions provider, today announces that, according to a recent milestone report by Finite State, an independent third-party cybersecurity firm, nearly 95% of all Quectel m…

Read more

Mobil 1 Marks 50th Anniversary with Celebratory Racing Liveries Throughout 2024 Motorsports Season

Mobil 1 will showcase specially designed full-car wraps and icons, created in collaboration with teams in IMSA, WEC, Formula 1, NASCAR, NHRA, MotoGP and more

 

(BUSINESS WIRE) -- To celebrate the 50th anniversary of Mobil 1™ motor oil, this year the brand will showcase more than 40 iconic…

Read more

Brightcove Simplifies Content Creation With New Intuitive Web-Based Video Editing Tool

 

rightcove’s web-based video editor helps marketers edit and distribute content across all devices and platforms, accelerating the video management and publishing workflow

(BUSINESS WIRE) -- Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, announced today…

Read more

Thales and Intel Enable Advanced Protection for the Google Cloud Ecosystem

 

  • Enables persistent protection of the most sensitive enterprise workloads in the cloud through customer-controlled data security, not observable by non-authorized parties
  • Protects against malicious actors accessing code and data at rest, in transit and while in use

Read more

Confident CEOs Reskill Companies for AI-Driven Future, Arthur D. Little Research Finds

LONDON - Thursday, 14. March 2024

(BUSINESS WIRE) -- Looking beyond current turbulence, the CEOs of the world’s largest companies are increasingly optimistic about future growth, with 66% highly positive about the global outlook over the next three to five years. This is the headline finding of t…

Read more

Consumer Packaged Goods Leader Church & Dwight Selects Rockwell Automation to Increase Manufacturing Cybersecurity Resilience

Church & Dwight partners with Rockwell Automation to uplevel OT cybersecurity program, implementing rigorous security standards

(BUSINESS WIRE) -- Rockwell Automation Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced it ha…

Read more

Lessengers Announces Industry-First Partially Retimed 800G Optical Transceivers for AI/ML Workloads

Company will unveil a comprehensive portfolio of 800G Optics for AI/ML at OFC 2024 in San Diego

(BUSINESS WIRE) -- LESSENGERS Inc., a provider of innovative optical components based on its patented “direct optical wiring” (DOW) technology, today announced a comprehensive portfolio of 800G optics …

Read more

Galderma @ AAD 2024: New Data Demonstrate the Long-Term Efficacy of Nemolizumab in Prurigo Nodularis and Its Durability in Atopic Dermatitis

Nemolizumab is a first-in-class investigational monoclonal antibody designed to provide relief from itch by targeting IL-31
One-year data from an interim analysis of the OLYMPIA long-term extension (LTE) study show that more than 80% of nemolizumab-treated patients with prurigo nodularis experience…

Read more

BeiGene Receives FDA Approval for TEVIMBRA® for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy

Results from the global, Phase 3 RATIONALE 302 trial showed TEVIMBRA prolonged the survival of patients who received prior systemic treatment compared to chemotherapy

Approval represents the first indication in the U.S. for TEVIMBRA

 

(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 061…

Read more

Esri’s Dr. Dawn Wright Selected for 2024 US Science Envoys

Chief Scientist of Esri to Be Among First All-Female Cohort in State Department Program’s History

(BUSINESS WIRE)--Esri, the global leader in location intelligence, is proud to announce that the US Department of State has selected the company’s chief scientist, Dr. Dawn Wright, among four disti…

Read more

DCAS Accepting Non-Dealer Committee Membership Applications for 2024

NEW YORK - Friday, 15. March 2024
(BUSINESS WIRE) -- DC Administration Services, Inc. (DCAS) would like to invite all interested Members of ISDA to apply for a position as a Non-dealer Committee Member of the Determinations Committee for the relevant region.

Parties wishing to apply for such a p…

Read more

Des aéronefs Cessna Grand Caravan de Textron Aviation seront livrés pour participer à des missions spéciales de sécurisation de la Corne de l’Afrique

WICHITA, Kansas - jeudi, 14. mars 2024

(BUSINESS WIRE)-- Textron Aviation annonce aujourd’hui la signature d’un contrat avec l'U.S. Army Contracting Command, Redstone Arsenal, AL, pour deux avions turbopropulseurs Cessna Grand Caravan EX. L’avion sera détenu et exploité par l’Armée de l’air djibo…

Read more

First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation

SEATTLE & BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. - Wednesday, 13. March 2024 AETOSWire 
Armenia and Nepal are the first of 29 countries to receive BRUKINSA

(BUSINESS WIRE) -- The Max Foundation (Max), a global nonprofit organization dedicated to accelerating health equity by delivering…

Read more

Thales Partners with Neural Labs to Support AI-Powered Smart Cities

  • Partnership spanning two decades expands to incorporate cloud licensing
  • SaaS capabilities will enable Neural Labs to deploy and update licenses from any location for their customers and resellers

 

 
 
(BUSINESS WIRE)--Thales, a global leader in Software Monetization …

Read more

Pacific Prime Wins Cigna’s Top Producer 2023 Individuals Award

 

(BUSINESS WIRE) -- Global health insurance brokerage Pacific Prime Dubai has been awarded Top Producer 2023 Individuals with Cigna for their excellent performance in Dubai under the category of Individual Brokers.

The award was presented by Leah Cotterill, Chief Distribution Officer o…

Read more

Cloudflare Doubles Down on Middle East; Expands Presence and Team to Support Growing Customer Demand

 

 

Company increases investment in Middle East as rapid digital transformation of the region continues

(BUSINESS WIRE) -- Cloudflare, Inc. (NYSE: NET), the leading connectivity cloud company, today announced it is pushing forward with aggressive investment plans in the Middle East fur…

Read more

United for Bitcoin: 20+ Crypto Organizations Join Global Bitcoin Emoji Initiative

VILNIUS, Lithuania - Wednesday, 13. March 2024

Crypto companies, non-profit organizations, decentralized communities, and VC funds join hands to push for an official Bitcoin emoji, added to all digital keyboards

 

(BUSINESS WIRE)--20+ leading crypto organizations including BTC Inc, Bitget,…

Read more

Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia

− Pre-Specified Interim Analysis Shows Positive Safety and Efficacy Results; Mezagitamab Safe and Well Tolerated

− Takeda Intends to Initiate a Global Phase 3 Trial of Mezagitamab in Patients with Primary Immune Thrombocytopenia in Fiscal Year 2024

− Late-Stage Pipeline Continues to Gain M…

Read more

20 blog posts

Blog Sear

Comments

There are currently no blog comments.